TOPLINE: A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during the 2023-2024 respiratory illness season. This protection extends across age groups and immunocompromised individuals. METHODOLOGY: Researchers conducted a target trial emulation study to evaluate the real-world effectiveness of […]
The post New RSV Vaccine Shows Strong Protection in Veterans first appeared on News Health.
Author : News Health
Publish date : 2025-03-18 09:32:00
Copyright for syndicated content belongs to the linked Source.